PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
26-Mar-2025 Global Demand for Wearable Medical Devices Market With Double-Digit Growth Medi-Tech Insights
26-Mar-2025 Futurewise Research Unveils Comprehensive Actinic Keratosis Treatment Market Analysis for 2025 and Beyond Futurewise Research
26-Mar-2025 Laser Hair Removal Market Size, Share, Demand | CAGR of 17-19% by 2028 Medi-Tech Insights
26-Mar-2025 Mesenchymal Stem Cells Market Size | USD 10182.3 Mn & CAGR 13.5% Growth By 2032 Vantage Market Research
26-Mar-2025 Healthcare professionals on social media praise “historic milestones” and “important steps forward” as latest oncology treatments approved Creation Healthcare
26-Mar-2025 Global Breast Imaging Market Size, Share, and Industry Analysis Report - Forecast to 2028 Medi-Tech Insights
26-Mar-2025 New Publication Reveals the Impact of Socioeconomic Factors on Health Outcomes and Importance of Self-Care Bayer
26-Mar-2025 New study results reinforce Tagrisso as the backbone therapy for EGFR-mutated lung cancer across stages and settings AstraZeneca
26-Mar-2025 NHSBSA publishes new exploratory analysis on PPC patient savings The NHS Business Services Authority (NHSBSA)
26-Mar-2025 Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025 Heidelberg Pharma
26-Mar-2025 Asgard Therapeutics appoints immunology expert Shane Olwill as Chief Development Officer Asgard Therapeutics
26-Mar-2025 Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract infections (uUTIs) in female adults and paediatric patients 12 years of age and older GSK
26-Mar-2025 Pleco Therapeutics Announces Positive Outcome of Pre-IND meeting with FDA for PTX-252 in Acute Myeloid Leukaemia Pleco Therapeutics
26-Mar-2025 ONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb Mobility ONWARD Medical
26-Mar-2025 Chlamydia vaccine candidate granted fast track designation by the US FDA Sanofi
26-Mar-2025 Xcellbio Announces Partnership with Planet Innovation to Develop and Manufacture Next Generation Instruments to Improve potency for Rapid Cell Therapy Manufacturing Xcellbio
26-Mar-2025 Genmab Announces Initiation of Share Buy-Back Program Genmab
26-Mar-2025 iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor at the American Association for Cancer Research Annual Meeting 2025 iTeos Therapeutics
26-Mar-2025 Nouscom to Present Final Results from Successful Phase Ib/II Trial of NOUS-209 in People Living with Lynch Syndrome, Demonstrating Powerful Potential to Intercept Cancer in its Earliest Stages of Development Nouscom
26-Mar-2025 Tiziana Life Sciences Announces Yale University Commences Intranasal Foralumab Dosing in Phase 2 Multiple Sclerosis Trial Tiziana Life Sciences